Drug profile · INN
bendamustine hydrochloride
BENDAMUSTINE HYDROCHLORIDE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
bendamustine hydrochloride (BENDAMUSTINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: iv (infusion). Current US regulatory status: approved.
Key facts
Frequently asked questions
What is bendamustine hydrochloride?
bendamustine hydrochloride (BENDAMUSTINE HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Route of administration: iv (infusion). Current US regulatory status: approved.
What is the brand name for bendamustine hydrochloride?
BENDAMUSTINE HYDROCHLORIDE is a marketed brand name for bendamustine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bendamustine hydrochloride?
bendamustine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.